Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

EMD 121974 in Treating Patients With Progressive or Recurrent Glioma

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: August 3, 2000
Last updated: June 20, 2013
Last verified: April 2003
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2006
  Estimated Primary Completion Date: No date given
Nabors LB, Rosenfeld SS, Mikkelsen T, et al.: NABTT 9911: a phase I trial of EMD 121974 for treatment of patients with recurrent malignant gliomas. [Abstract] Neuro-Oncology 6 (4): TA-39, 379, 2004.